These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 377612)

  • 1. Causes and management of rejection.
    Najarian JS; Ascher NL
    Transplant Proc; 1979 Mar; 11(1):11-6. PubMed ID: 377612
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating antibodies in allograft recipients.
    Revillard JP; Betuel H
    Adv Nephrol Necker Hosp; 1975; 5():257-81. PubMed ID: 127522
    [No Abstract]   [Full Text] [Related]  

  • 3. The development and specificity of anti-B-cell antibodies during humoral rejection of kidney allografts.
    Hardy M; Suciu-Foca N; McKiernan T; Rohowsky C; Cianci J; Jacob J; Pierce J; Reemtsma K
    Transplant Proc; 1979 Mar; 11(1):389-92. PubMed ID: 377661
    [No Abstract]   [Full Text] [Related]  

  • 4. Preexistent anti-HLA-DR antibodies and kidney graft survival.
    Sirchia G; Mercuriali F; Scalamogna M; Rosso di San Secondo V; Pizzi C; Poli F; Fortis C; Greppi N
    Transplant Proc; 1979 Mar; 11(1):950-3. PubMed ID: 377727
    [No Abstract]   [Full Text] [Related]  

  • 5. Pretransplant dialysis and blood transfusion--correlation with cadaveric kidney graft survival.
    Fehrman I; Groth CG; Lundgren G; Magnusson G; Möller E
    Transplant Proc; 1979 Mar; 11(1):152-5. PubMed ID: 377622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-D antigen disparity and HLA-DRw antibodies in intrafamilial renal allograft survival.
    Cochrum K; Hanes D; Van Speybroeck J; Perkins H; Ferrone S; Indeveri F; Amend W; Vincenti F; Feduska N; Salvatierra O
    Transplant Proc; 1979 Mar; 11(1):404-10. PubMed ID: 156426
    [No Abstract]   [Full Text] [Related]  

  • 7. Uremic patients immunized with planned blood transfusions: detection of HLA antibodies with the cytotoxic test and an indirect rosette microassay.
    Indiveri F; Fagiolo U; Pellegrino MA; Ferrone S
    Transplant Proc; 1979 Mar; 11(1):167-70. PubMed ID: 377624
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP
    Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
    [No Abstract]   [Full Text] [Related]  

  • 9. The positive B-cell cross-match: a marker of active enhancement?
    d'Apice AJ; Tait BD
    Transplant Proc; 1979 Mar; 11(1):954-7. PubMed ID: 377728
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful bone marrow transplantation in sensitized recipients.
    Levey RH; Parkman R; Rappeport J; Nathan DG; Rosen F
    Transplant Proc; 1979 Mar; 11(1):199-204. PubMed ID: 377631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procedure in highly immunized patients treated with kidney transplants.
    Kirste G; Keller H; Fischer J; Wilms H
    Transplant Proc; 1988 Oct; 20(5):949-50. PubMed ID: 3055539
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo - in vitro correlates of antithymocyte globulin (ATG) immunosuppression in the human.
    Thomas F; Berry R; Mendez-Picon G; Thomas J; Lower RR; Lee HM
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():56-61. PubMed ID: 386321
    [No Abstract]   [Full Text] [Related]  

  • 13. Progress in clinical renal transplantation.
    Williams GM
    Transplant Proc; 1979 Mar; 11(1):4-10. PubMed ID: 377665
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of rat renal allograft rejection by antibody against lymphocyte antigen receptors.
    McKearn TJ; Finnegan A; Neu MR; Fitch FW; Stuart FP
    Surg Forum; 1974; 25(0):263-5. PubMed ID: 4612772
    [No Abstract]   [Full Text] [Related]  

  • 15. The improving prognosis after kidney transplantation. New strategies to overcome immunologic rejection.
    Levey AS
    Arch Intern Med; 1984 Dec; 144(12):2382-7. PubMed ID: 6391406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches to immunosuppression in renal transplantation.
    Stuart FP
    Urol Clin North Am; 1976 Oct; 3(3):575-96. PubMed ID: 790732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous antilymphocyte globulin in human cadaveric renal allotransplantation. Clinical and immunologic observations.
    Collste LG
    Acta Chir Scand; 1972; 138(8):765-74. PubMed ID: 4565721
    [No Abstract]   [Full Text] [Related]  

  • 18. B-lymphocyte-specific antibodies in human renal allografts.
    Mohanakumar T; Giedlin M; DuVall C; Rhodes C; Phibbs M; Mendez G; Kaplan AM; Lee HM
    Transplant Proc; 1979 Mar; 11(1):397-400. PubMed ID: 377664
    [No Abstract]   [Full Text] [Related]  

  • 19. Dilutions and specificity analysis of pretransplant sera.
    Iwaki Y; Terasaki PI; Park MS; Heintz R; Silberman H; Berne T
    Transplant Proc; 1979 Mar; 11(1):944-9. PubMed ID: 377726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific suppression of organ graft rejection.
    Fabre JW
    Proc R Soc Med; 1976 Jul; 69(7):528-30. PubMed ID: 785480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.